Ken Griffin Bristol Myers Squibb CO Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Citadel Advisors LLC holds 6,918,500 shares of BMY stock, worth $400 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

6,918,500

Previous 8,858,400 21.9%

Holding current value

$400 Million

Previous $368 Million 2.68%

% of portfolio

0.07%

Previous 0.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $233 Million - $305 Million	-5,885,542 Reduced 53.64%	5,086,135 $263 Million
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $429 Million - $565 Million	10,660,102 Added 3421.36%	10,971,677 $456 Million
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $128 Million - $145 Million	-2,674,467 Reduced 89.57%	311,575 $16.9 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $103 Million - $123 Million	2,125,298 Added 246.91%	2,986,042 $153 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $19 Million - $21.2 Million	-327,865 Reduced 27.58%	860,744 $50 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $52.2 Million - $58 Million	819,242 Added 221.8%	1,188,609 $76 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $178 Million - $202 Million	-2,710,185 Reduced 88.01%	369,367 $25.6 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $196 Million - $232 Million	2,857,109 Added 1284.42%	3,079,552 $222 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $98,636 - $58.3 Million	-758,746 Reduced 77.33%	222,443 $15.8 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $42.5 Million - $46.8 Million	584,567 Added 147.39%	981,189 $75.6 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $15.6 Million - $18.7 Million	-254,136 Reduced 39.05%	396,622 $29 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $4.09 Million - $4.77 Million	-76,301 Reduced 10.49%	650,758 $40.6 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $78.9 Million - $92.4 Million	-1,332,962 Reduced 64.71%	727,059 $43 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $17.5 Million - $19 Million	-282,516 Reduced 12.06%	2,060,021 $138 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $132 Million - $149 Million	2,232,421 Added 2027.34%	2,342,537 $148 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $404 Million - $458 Million	-6,995,645 Reduced 98.45%	110,116 $6.83 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $62.1 Million - $68.8 Million	1,081,490 Added 17.95%	7,105,761 $428 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $258 Million - $301 Million	4,703,377 Added 356.08%	6,024,271 $354 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $67.7 Million - $98.4 Million	-1,459,837 Reduced 52.5%	1,320,894 $73.6 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $87 Million - $113 Million	1,767,691 Added 174.49%	2,780,731 $178 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $144 Million - $171 Million	-3,376,244 Reduced 76.92%	1,013,040 $51.4 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $58.5 Million - $64.7 Million	1,311,875 Added 42.63%	4,389,284 $199 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $46.1 Million - $54.9 Million	1,021,015 Added 49.65%	3,077,409 $0
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $98.6 Million - $128 Million	-2,022,021 Reduced 49.58%	2,056,394 $107 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $4.67 Million - $5.27 Million	-84,614 Reduced 2.03%	4,078,415 $0
Q2 2018 Aug 10, 2018	SELL	$50.53 - $62.98 $11 Million - $13.7 Million	-216,798 Reduced 4.95%	4,163,029 $0
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $89.1 Million - $103 Million	-1,487,119 Reduced 25.35%	4,379,827 $277 Million
Q4 2017 Feb 09, 2018	BUY	$59.94 - $65.35 $224 Million - $245 Million	3,745,139 Added 176.51%	5,866,946 $360 Million
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $117 Million - $135 Million	2,121,807	2,121,807 $135 Million

Others Institutions Holding BMY

# of Institutions

2,532

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account